Implications of Healthcare Reform: 'No' Will Be Heard is led by Cliff Goodman, PhD, in a panel discussion featuring A. Mark Fendrick, MD, co-editor in chief of The American Journal of Managed Care, John L. Fox, MD, MHA, and Ira M. Klein, MD, MBA, FACP. The panelists determine what it means when a patient says no.
“Implications of Healthcare Reform: ‘No’ Will Be Heard” is led by Cliff Goodman, PhD, in a panel discussion featuring A. Mark Fendrick, MD, co-editor in chief of The American Journal of Managed Care, John L. Fox, MD, MHA, and Ira M. Klein, MD, MBA, FACP. The panelists determine what it means when a patient says “no.”
Dr Fox says that payers don’t want to be in a position that interposes them between patients and providers. “We can’t expect that patients are always going to make rational decisions, but we can certainly expect that patients be afforded the opportunity to make their choices known, and to have their choices respected.” Dr Fox adds that the challenge is that all too often, patients don’t have the opportunity to make their decisions known until it is too late.
Dr Ira Klein agrees with Dr Fox, saying that the “no” conversation between providers and payers is sometimes necessary. “The patients are often, and this is not their fault, not fully informed as to what it is that is requested, and what the repercussions and ramifications are,” says Dr Klein. “How people feel about care affects utilization, and for them to feel anything about care, they have to understand care and there has to be a little bit more transparency. So it doesn’t mean we’re going to take all our patients and turn them into amateur oncologists, it just means that they should have access to a little bit more understanding about what it is going to happen to them from the beginning, the middle, and the end.” He adds that how and when you say no is related to the stakeholders at hand.
Dr Fendrick then asks, “When does no really mean no?” He suggests that having the “no” discussion, which is actually pretty rare, to shift from “easier to get, to less to get.” He says that it is important for all stakeholders to ration harmful care, or care that is known to be harmful.
The panelists continue discussions on issues including the impact of healthcare reform and payment delivery on patient engagement, and how “no” might lead to problems such as underuse.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen